Oppenheimer Asset Management Inc. NEUROCRINE BIOSCIENCES INC Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

Shares

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 08, 2022	SELL	N/A	-78,000 Closed	0 $0
Q1 2022 May 12, 2022	SELL	N/A	-2,000 Reduced 2.5%	78,000 $102,000
Q4 2021 Feb 02, 2022	SELL	N/A	-5,000 Reduced 5.88%	80,000 $100,000
Q3 2021 Nov 12, 2021	SELL	N/A	-3,000 Reduced 3.41%	85,000 $113,000
Q2 2021 Aug 03, 2021	BUY	N/A	18,000 Added 25.71%	88,000 $118,000
Q1 2021 May 17, 2021	BUY	N/A	1,000 Added 1.45%	70,000 $94,000
Q4 2020 Feb 11, 2021	SELL	N/A	-3,000 Reduced 4.17%	69,000 $95,000
Q3 2020 Nov 13, 2020	BUY	N/A	1,000 Added 1.41%	72,000 $99,000
Q4 2019 Feb 07, 2020	SELL	N/A	-4,000 Reduced 5.33%	71,000 $109,000
Q2 2019 Aug 09, 2019	BUY	N/A	5,000 Added 7.14%	75,000 $98,000
Q1 2019 Apr 24, 2019	BUY	N/A	10,000 Added 16.67%	70,000 $95,000
Q4 2018 Jan 30, 2019	SELL	N/A	-15,000 Reduced 20.0%	60,000 $72,000
Q3 2018 Oct 26, 2018	BUY	N/A	2,000 Added 2.74%	75,000 $128,000
Q2 2018 Aug 10, 2018	BUY	N/A	73,000 New	73,000 $105,000

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.